Sign inJoin waitlistJoin the waitlist

Michael Rosenbloom

Director of UW MBWC Clinical Trials · University of Washington School of Medicine

Credentials: · · · · · · ·

History

Center for Memory and Aging · University of Minnesota
Present
University of Washington School of Medicine
Present

Veterans Affairs Medical Center
2009–2010
University of California-San Francisco
2008–2009
Neurology
Brigham and Women's Hospital
2005–2008
Bassett Medical Center
2004–2005
Columbia Univ Coll of Phys & Surgeons
2000–2004

Research

Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution
Neurology · 2011 · First of 17 authors · Corresponding · 92 citations
The functional neuroanatomy of decision-making
The Journal of neuropsychiatry and clinical neurosciences · 2012 · First of 3 authors · Corresponding · 85 citations
A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein E4 carriers with mild-moderate Alzheimer's disease
CNS Drugs · 2014 · First of 8 authors · Corresponding · 52 citations

Bruce Miller
3 papers
DW
David Weisman
3 papers
KP
Katherine Possin
3 papers
Soo Borson
3 papers
Gil Rabinovici
2 papers
Hillary Lum
2 papers
MG
Michael Geschwind
2 papers
Alireza Atri
1 paper
Andrew Budson
1 paper
Aneesh Singhal
1 paper
Annika Oie
1 paper · 1 as a resident
BB
Brent Berry
1 paper · 1 as a fellow

Clinical trials

Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
Principal investigator · Terminated · Phase 2
HealthPartners Institute
2015–2019
Investigation of the Safety of Intranasal Glulisine in Down Syndrome
Principal investigator · Completed · Phase 1
HealthPartners Institute
2015–2018
Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.
Principal investigator · Completed · Phase 2
HealthPartners Institute
2011–2013